Results 171 to 180 of about 584,992 (269)

Content Analysis of Responses From an INSAR Special Interest Group (SIG): Indigenous Perspectives on Autism

Autism Research, EarlyView.
ABSTRACT Autism remains understudied and under‐detected in Indigenous communities across the globe. This content analysis investigates key themes and future directions for Indigenous autism research, as discussed during a Special Interest Group at the 2025 International Society for Autism Research meeting in Seattle, United States.
Grant Bruno, Annie Tang, Troy Q. Boucher, Emily Coombs, T. C. Waisman, Anne Lindblom   +5 more
wiley   +1 more source

A novel protein truncating mutation of TTC8 causes Bardet-Biedl Syndrome (BBS) in a Pakistani family. [PDF]

Genet Mol Biol
Fatima S, Sun D, Han J, Qiu M, Ahmad S, Zubair M, Ali MZ, Abbas S, Shafiq M, Muzammal M, Gul H, Khan J, Du S, Khan MA.   +13 more
europepmc   +1 more source

A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients

British Journal of Clinical Pharmacology, EarlyView.
Aim Enoxaparin dosing in burn patients is challenging due to physiological changes affecting absorption, distribution and clearance. The objectives of this study are to develop a population pharmacokinetic (PK) model for enoxaparin in burn patients, evaluate target attainment with current equation‐based (EQ) dosing and propose an optimized dosing ...
Babajide Shenkoya, Venkata Yellepeddi, Ann Marie B. Prazak, Mathangi Gopalakrishnan   +3 more
wiley   +1 more source

Leader-Independent C‑Terminal Modification by a Radical <i>S</i>‑Adenosyl‑l‑methionine Maturase Enables Macrocyclic GLP-1-Like Peptides. [PDF]

ACS Bio Med Chem Au
Pedigo JK, Eastman KAS, Bandarian V.
europepmc   +1 more source

Model‐informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims This study aimed to develop and validate a population pharmacokinetic‐pharmacodynamic (pop‐PK‐PD) model to describe carboplatin‐induced myelosuppression in cancer patients and support dose individualization. Methods Data from 580 cancer patients treated with carboplatin at Amsterdam UMC between 2019 and 2022 were used for model ...
Alessandro De Carlo, Elena Maria Tosca, Mirjam Crul, Tim Schutte, Lia van Zuijlen, Idris Bahce, Medhat M. Said, Jan Buter, Harmen Huls, Paolo Magni, Imke Bartelink   +10 more
wiley   +1 more source

Pediatric reflex syncope: updated insights and future directions. [PDF]

Eur J Pediatr
Russo V, Comune A, Di Nardo G, Di Marco GM, Gaudieri G, Parente E, Caturano A, Papa AA, Rago A, Russo MG, Nigro G.   +10 more
europepmc   +1 more source

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Children with primary immunodeficiency (PID) and secondary antibody deficiency (SAD) often require immunoglobulin replacement therapy due to low plasma immunoglobulin G (IgG) levels and recurrent infections. Existing pharmacokinetic models for immunoglobulin in PID patients predominantly focus on adults, with limited attention to ...
Iek Leng Cheng, Zhong Hui Huang, Austen Worth, Claire Booth, Joseph F. Standing   +4 more
wiley   +1 more source

Ravulizumab in the Management of Refractory Myasthenic Crisis: Clinical and Ventilatory Evidence of Early Recovery-A Case Report. [PDF]

Case Rep Neurol Med
Manlio Sgarzi, Paolo Paone, Paolo Gritti, Emanuela Agazzi, Giorgia Camera, Dario Alimonti.   +5 more
europepmc   +1 more source

Caps & Capes - February 1963 [PDF]

, 1963
Papa, Simone
core   +1 more source

Edaphic homologous zones and digital tools as a basis for sustainable soil management in potato growing areas in Colombia. [PDF]

Sci Rep
Leon-Rueda WA, Cárdenas-Urrego WF, Niño-Medina RC, Ramirez-Gil JG.   +3 more
europepmc   +1 more source